FATE
Fate Therapeutics Inc
2.30$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -756.8% | -677.5% | -898.8% | -815.4% | -778.8% | -124.8% | -291.6% | -257.7% | -208.2% | -901.4% | -1,596.2% | |
| – | 28.3% | 20.0% | 23.6% | 25.4% | 20.5% | 9.8% | 10.5% | 14.3% | 28.8% | 139.1% | 139.9% | |
| – | 98.7% | 72.3% | 87.8% | 132.8% | 163.0% | 97.8% | 97.3% | 81.8% | 68.4% | 304.4% | 375.0% | |
| – | 124.5% | 83.3% | 122.8% | 144.7% | 163.0% | 97.8% | 66.9% | 53.8% | – | – | – | |
| – | 15.2% | 26.8% | 50.7% | 36.8% | 34.1% | -40.6% | 3.8% | -36.0% | 30.2% | -14.4% | -56.3% | |
| – | 61.6% | 10.4% | 42.0% | 48.6% | 69.2% | 15.7% | 90.8% | 36.9% | 9.7% | 5.4% | 89.6% | |
| – | -61.6% | -93.5% | -248.3% | -9.8% | -1,474.3% | -512.4% | -580.2% | 173.2% | 177.3% | 89.6% | 1,672.7% | |
| – | 17.3% | 4.2% | 370.3% | – | 23.6% | – | – | – | – | – | – | |
| – | 17.3% | 4.2% | -4.7% | 56.8% | 23.6% | 790.3% | 774.4% | – | – | – | – | |
| – | -63.6% | -174.7% | 102.9% | -316.5% | -140.4% | – | 0.0% | – | – | – | – | |
| – | 1,464.5% | 1,311.6% | 1,155.5% | 2,970.0% | 1,403.8% | 899.8% | 811.4% | 9.6% | 0.1% | 732.8% | 82.6% | |
| – | 646.2% | 540.7% | 8.4% | 2,144.9% | -849.3% | 214.8% | -60.5% | -75.0% | -30.6% | -42.7% | 159.1% | |
| – | -818.4% | -687.9% | -940.8% | -864.0% | -848.0% | -140.5% | -382.4% | -294.7% | -217.9% | -906.8% | -1,685.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.